Zhejiang CONBA PharmaceuticalLtd Balance Sheet Health
Financial Health criteria checks 6/6
Zhejiang CONBA PharmaceuticalLtd has a total shareholder equity of CN¥6.8B and total debt of CN¥420.8M, which brings its debt-to-equity ratio to 6.2%. Its total assets and total liabilities are CN¥9.7B and CN¥3.0B respectively. Zhejiang CONBA PharmaceuticalLtd's EBIT is CN¥409.8M making its interest coverage ratio -5.5. It has cash and short-term investments of CN¥803.2M.
Key information
6.2%
Debt to equity ratio
CN¥420.77m
Debt
| Interest coverage ratio | -5.5x |
| Cash | CN¥803.16m |
| Equity | CN¥6.75b |
| Total liabilities | CN¥2.99b |
| Total assets | CN¥9.75b |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: 600572's short term assets (CN¥4.4B) exceed its short term liabilities (CN¥2.5B).
Long Term Liabilities: 600572's short term assets (CN¥4.4B) exceed its long term liabilities (CN¥536.0M).
Debt to Equity History and Analysis
Debt Level: 600572 has more cash than its total debt.
Reducing Debt: 600572's debt to equity ratio has reduced from 55.6% to 6.2% over the past 5 years.
Debt Coverage: 600572's debt is well covered by operating cash flow (166%).
Interest Coverage: 600572 earns more interest than it pays, so coverage of interest payments is not a concern.